Literature DB >> 21768396

Cutting edge: HLA-DO impairs the incorporation of HLA-DM into exosomes.

Fangming Xiu1, Marie-Hélène Côté, Marie-Claude Bourgeois-Daigneault, Alexandre Brunet, Marie-Élaine Gauvreau, Andrew Shaw, Jacques Thibodeau.   

Abstract

In multivesicular bodies, HLA-DM (DM) assists the loading of antigenic peptides on classical MHC class II molecules such as HLA-DR. In cells expressing HLA-DO (DO), DM is redistributed from the internal vesicles to the limiting membrane of these organelles. This suggests that DO might reduce DM incorporation into exosomes, which are shed upon fusion of multivesicular bodies with the plasma membrane. To test this hypothesis, we used the 721.45 B lymphoblastoid cell line and different HeLa cell transfectants. We demonstrate that the poor recovery of DM in exosomes as compared with HLA-DR is not the mere reflection of differences in protein expression. Indeed, we found that DO contributes to the inefficient transfer of DM to exosomes. This negative regulation requires an intact di-leucine endosomal sorting motif in the cytoplasmic tail of HLA-DOβ. These results demonstrate that canonical sorting signals and protein-protein interactions modulate the selection of MHC protein cargos.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768396     DOI: 10.4049/jimmunol.1100199

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

2.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.

Authors:  Taejin Yoon; Henriette Macmillan; Sarah E Mortimer; Wei Jiang; Cornelia H Rinderknecht; Lawrence J Stern; Elizabeth D Mellins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 3.  The immunobiology of ubiquitin-dependent B cell receptor functions.

Authors:  James R Drake
Journal:  Mol Immunol       Date:  2018-06-26       Impact factor: 4.407

Review 4.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.

Authors:  Jason M God; Christine Cameron; Janette Figueroa; Shereen Amria; Azim Hossain; Bettina Kempkes; Georg W Bornkamm; Robert K Stuart; Janice S Blum; Azizul Haque
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 6.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

7.  Host genetics and immune control of HIV-1 infection: fine mapping for the extended human MHC region in an African cohort.

Authors:  H A Prentice; N M Pajewski; D He; K Zhang; E E Brown; W Kilembe; S Allen; E Hunter; R A Kaslow; J Tang
Journal:  Genes Immun       Date:  2014-05-01       Impact factor: 2.676

Review 8.  The Other Function: Class II-Restricted Antigen Presentation by B Cells.

Authors:  Lital N Adler; Wei Jiang; Kartik Bhamidipati; Matthew Millican; Claudia Macaubas; Shu-Chen Hung; Elizabeth D Mellins
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

9.  Ubiquitination of HLA-DO by MARCH family E3 ligases.

Authors:  Martin Jahnke; John Trowsdale; Adrian P Kelly
Journal:  Eur J Immunol       Date:  2013-03-11       Impact factor: 5.532

10.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.